Corrigendum to “Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774)” [Eur Urol. 86(1) (2024) 52-60]

By sjmartinez • November 14, 2024

Armstrong WR, Kishan AU, Booker KM, Grogan TR, Elashoff D, Lam EC, Clark KJ, Steinberg ML, Fendler WP, Hope TA, Nickols NG, Czernin J, Calais J. Corrigendum to "Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774)" [Eur Urol. 86(1) (2024) 52-60]. Eur Urol. 2024 Nov 8:S0302-2838(24)02684-8. doi: 10.1016/j.eururo.2024.10.022. Epub ahead of print. Erratum for: Eur Urol. 2024 Jul;86(1):52-60. doi: 10.1016/j.eururo.2024.01.012. PMID: 39521695.

Tags: Cardiology/Epi, DOM STAT, General Internal Medicine, Publications

Intracoronary acetylcholine for vasospasm provocation in women with ischemia and no obstructive coronary artery disease

Tjoe B, Pacheco C, Suppogu N, Samuels B, Rezaeian P, Tamarappoo B, Berman DS, Sharif B, Nelson M, Anderson RD, Petersen J, Pepine CJ, Thomson[...]

18F flurpiridaz PET MPI: Imaging characteristics and clinical trials

Maddahi J. 18F flurpiridaz PET MPI: Imaging characteristics and clinical trials. J Nucl Cardiol. 2025 Mar;45S:102175. doi: 10.1016/j.nuclcard.2025.102175. Epub 2025 Mar 28. PMID: 40180504.

Mass spectrometric profiling of primary estrogens and estrogen metabolites in human stool and plasma partially elucidates the role of the gut microbiome in estrogen recycling

Li VW, Dong TS, Funes D, Hernandez L, Kushnir NR, Nair D, Jacobs JP, Reddy ST, Mayer EA, Chang L, Meriwether D. Mass spectrometric profiling[...]